Indian markets traded flat as investors awaited the RBI's policy decision. Pharma stocks slipped after Trump's tariff warning, while defence stocks surged on DAC's ₹67,000 crore project approval. FIIs sold ₹20 crore in cash and added fresh index shorts, signalling caution. Analysts expect weak sentiment to persist unless Nifty sustains above 24,900.